Medically reviewed by Mary Choy, PharmD Adderall (amphetamine/dextroamphetamine) is a central nervous system (CNS) stimulant ...

More than two years after acquiring Tarus Therapeutics, Portage Biotech is relaunching Tarus’ adenosine receptor antagonists ...

About Portage Biotech, Inc. Portage Biotech is a clinical-stage immuno-oncology company advancing a pipeline of novel biologics to transform the immune system’s ability to fight cancer. For more ...

Portage Biotech (PRTG) announced the re-launch of its wholly-owned subsidiary as an independently managed company focused on developing ...

Zimberelimab is under clinical development by Arcus Biosciences and currently in Phase II for Pancreatic Ductal Adenocarcinoma.

Domvanalimab is under clinical development by Arcus Biosciences and currently in Phase I for Glioblastoma Multiforme (GBM).

Adenosine deaminase 2 (ADA2) has been identified as a regulator of toll-like receptor 9 (TLR9) activation in response to nucleic acids, according to a recent study. ADA2, previously known for its ...

“For healthy adults, caffeine consumption is relatively safe, but for some vulnerable populations, caffeine consumption could ...

Cell-surface receptors are crucial for cells to sense and respond to the environment. After binding to a specific chemical outside the cell, the membrane-spanning proteins trigger signalling ...

This paper provides a valuable contribution to our understanding of how adenosine acts as a signal of nutrient insufficiency and extends this idea to suggest that adenosine is released by ...

Traditional therapies targeting androgen receptor (AR) signaling have limited efficacy. In a recent study, researchers investigated the potential of azolato-bridged dinuclear platinum(II ...